【正文】 cal market, analyzes the strategic layout of China39。s pharmaceutical supply chain problems from the perspective of economics and institutional ethics, and puts forward the basic idea of China39。s pharmaceutical market. This paper analyzes the status quo, operation mode, existing problems, development direction and case of the Chinese medicine factory, wholesalers, hospitals, pharmacies, consumers, and analyzes the current implementation of the Drugs centralized tender procurement system, drug pricing mechanism, new drug development, the trial batch mechanism, the hospital economic pensation mechanism, etc.. The reasons for the problems in the pharmaceutical market in China are analyzed in this paper. According to the analysis of China39。s pharmaceutical supply chain management, and pointed out the theoretical significance and practical significance of the study of China39。 【關鍵詞】 醫(yī)藥流通行業(yè)；企業(yè)；產業(yè)鏈；供應鏈；金融THESIS：Exploration on the mode of supply chain finance business in pharmaceutical circulation enterprises SPECIALIZATION： Master of Professional Accounting(MPAcc)POSTGRADUATE： the 2011 session, Xu WeinanMENTOR： Feng Qiaogen ProfessorABSTRACTPharmaceutical circulation industry is also an important supporting industry for social stability and development. Circulation of small and medium enterprises are mainly raw material suppliers or downstream drug distributors accounted for more than 90%, in the early stages of these pharmaceutical panies, internal financing can not meet their basic needs, for such panies generally do not meet the conditions listed on the market funds, private loans can not solve the problem of the fundamental solution to the problem of medical circulation. The main way of the mercial banks is external financing, because of the limitations of the pharmaceutical circulation enterprises and the imperfect mechanism of mercial banks, it can not solve the financing difficulties of small and mediumsized pharmaceutical circulation enterprises. In pharmaceutical circulation, the government39。論文對我國醫(yī)藥市場幾項重要制度進行了點評，分析了我國醫(yī)藥供應鏈戰(zhàn)略研究所面臨的環(huán)境構建了我國醫(yī)藥供應鏈的戰(zhàn)略布局，并預測了我國醫(yī)藥供應鏈的未來發(fā)展。論文根據我國醫(yī)藥市場的分析資料，從經濟學視角、制度倫理視角分析了我國醫(yī)藥供應鏈問題產生的原因和根源，論文提出了我國醫(yī)藥市場的混亂和異常現象從根本上說是我國醫(yī)藥供應鏈畸形所致的這一基本觀念，并從物流、信息流、資金流一一“三流合一”的角度分析了我國醫(yī)藥供應鏈存在的問題。論文分析了我國醫(yī)藥供應鏈中藥廠、批發(fā)商、醫(yī)院、藥店、消費者的現狀、運行模式、存在問題、發(fā)展方向和案例，分析了當前正在執(zhí)行的藥品集中招標采購制度、藥品定價機制、新藥研發(fā)、審批機制、醫(yī)院經濟補償機制等，指出了醫(yī)藥市場中存在的“市場失靈”和“政府失靈”的具體表現。并從我國政府對醫(yī)藥市場的管理觀念、管理機制、管理辦法和措施方面分析了我國醫(yī)藥供應鏈的政府管制特點，指出了研究我國醫(yī)藥供應鏈的理論意義和實踐意義。首先，論文對研究我國醫(yī)藥供應鏈的重要性和必要性進行了分析。破解中小流通醫(yī)藥企業(yè)的融資困難,和有關學者分析中小醫(yī)藥流通企業(yè)分析融資困難問題是關鍵，本文從各個方面提出了諸多措施，其中之一是供應鏈融資模式。商業(yè)銀行貸資的主要方式也是外部融資，由于醫(yī)藥流通企業(yè)本身的局限性和商業(yè)銀行的機制的不完善，使其不能從根本上解決中小型醫(yī)藥流通企業(yè)的融資困難，醫(yī)藥流通企業(yè)融資困難已經成為了公認的事實。 專業(yè)學位（碩士）論文 論文題目：醫(yī)藥流通企業(yè)供應鏈金融業(yè)務模式探索作 者： 徐偉楠 專 業(yè)： 會計碩士（MPAcc） 研究方向： 校內導師： 馮巧根 教授 校外導師： 杜文毅 高級會計師 二〇一五年九月二十六日 學號： 姓名：徐偉楠 論文答辯日期： 2015年 11 月 1日指 導 教 師： 41 / 51南京大學研究生畢業(yè)論文中文摘要首頁用紙 畢業(yè)論文題目：醫(yī)藥流通企業(yè)供應鏈金融業(yè)務模式探索 會計碩士（MPAcc）專業(yè) 2011 級碩士生姓名：徐偉楠 指導教師（姓名、職稱）： 馮巧根 教授 中 文 摘 要 醫(yī)藥流通行業(yè)也是社會穩(wěn)定和靜發(fā)展的重要支撐性產業(yè)。流通的中小企業(yè)主要原材料供應商或下游藥品分銷商占90%以上,在早期階段這些醫(yī)藥流通公司,內部融資無法滿足其基本需求,對于這樣的公司一般不符合上市的條件,關于本市場基金、私人貸款很多缺點都不能從根本解決醫(yī)藥流通的資金融資問題。在醫(yī)藥流通中,政府的政策支持中小醫(yī)藥流通企業(yè)，銀行應該盡快完善其機制業(yè)務，但是在融資方面，中小流通醫(yī)藥企業(yè)融資困難的問題沒有被解決。通過供應鏈融資業(yè)務，供應鏈核心企業(yè)的信用已將其放大化，依照這樣看來，中小流通醫(yī)藥企業(yè)的信用得以提升，進而促進融資能力得到不斷的增強，解決融資困難的問題。論文從醫(yī)藥行業(yè)的產品特性、行業(yè)主體特性、自身運行特性等三個方面分析了醫(yī)藥供應鏈相對于一般產業(yè)供應鏈的特殊性。其次，系統(tǒng)深入地分析了我國醫(yī)藥市場的現狀和存在的問題。論文對我國醫(yī)藥市場存在問題的原因進行了分析。并對我國醫(yī)藥供應鏈的發(fā)展進行了戰(zhàn)略分析。最后，論文從政府觀念、醫(yī)藥體制、制度設計、產業(yè)發(fā)展等方面提出了我國醫(yī)藥供應鏈發(fā)展和管理的政策建議，旨在降低供應鏈中的壟斷程度、減少信息不對稱、打擊權力尋租、提高產業(yè)競爭力和供應鏈運行效率，最終達到增加消費者福利，促進醫(yī)藥企業(yè)和醫(yī)藥市場的健康發(fā)展。s policy support for small and medium pharmaceutical circulation enterprises, banks should improve its mechanism as soon as possible, but in financing, small and medium enterprises financing difficulties of financing is not resolved. To solve the financing difficulties of small and medium sized enterprises, and to analyze the financing difficulties of small and medium sized pharmaceutical enterprises, the paper puts forward many measures from various aspects, one of which is supply chain financing model. Through supply chain financing business, supply chain core enterprise credit has been enlarged, according to this view, small and medium circulation medicine enterprise credit can be improved, and then promote the financing ability to get continuous enhancement, solve the problem of financing difficulties. First of all, the paper analyzes the importance and necessity of the research of Chinese medicine supply chain. This paper analyzes the particularity of the supply chain of pharmaceutical supply chain from three aspects: the characteristics of the pharmaceutical industry, the main characteristics of the industry, and the characteristics of its operation. From the Chinese government to the pharmaceutical market management concept, management mechanism, management methods and measures to analyze the characteristics of China39。s pharmaceutical supply chain. Secondly, it analyzes the current situation and problems of China39。s pharmaceutical market, the paper analyzes the causes and causes of China39。s medical supply chain. The strategic analysis of the development of Chinese medicine supply chain is carried out. This paper reviews some important systems of China39。s pharmaceutical supply chain, and predicts the future development of China39。s pharmaceutical supply chain from the aspects of government concept, medical system, system design, industry development. It aims to reduce the degree of monopoly, reduce information asymmetry, bat power rent seeking, improve industrial petitiveness and supply chain operation efficiency, and ultimately increase consumer welfare, promote th